6533b828fe1ef96bd12883b8

RESEARCH PRODUCT

Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their caregivers.

Michele PilatoTiziana CarolloPatrizio VituloMariachiara IppolitoGennaro MartucciGiovanna PanarelloAntonino GiarratanoCristina SantonocitoAntonio ArcadipaneAlessandro BertaniFilippo Sanfilippo

subject

AdultMaleARDSPediatricsmedicine.medical_specialtyPopulationAnxietyStress Disorders Post-Traumatic03 medical and health sciences0302 clinical medicineExtracorporeal Membrane OxygenationTracheostomyQuality of life030202 anesthesiologyIntensive careMedicineHumansSurvivorseducationDepression (differential diagnoses)Retrospective StudiesPatient health questionnaireeducation.field_of_studyPsychological TestsRespiratory Distress Syndromebusiness.industryDepression030208 emergency & critical care medicineRetrospective cohort studyRecovery of FunctionLength of StayMiddle Agedmedicine.diseasePatient Health QuestionnaireCritical careAnesthesiology and Pain MedicineTreatment OutcomeCaregiversQuality of LifeAnxietyFemalemedicine.symptombusinessFollow-Up Studies

description

Background Acute respiratory distress syndrome (ARDS) survivors are affected with long-term physical/mental impairments, with improvements limited mostly to the first year after intensive care (ICU) discharge. Furthermore, caregivers of ICU patients exhibit psychological problems after family-member recovery. We evaluated the long-term physical and mental recovery of ARDS survivors treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO), and the long-term psychological impact on their caregivers. Methods Single-center prospective evaluation of a retrospective cohort of 75 ARDS patients treated with VV-ECMO during a seven-year period (25.10.2009-11.08.2016). Primary outcomes were the 36-Item Short-Form Health-Survey (SF-36, patients only), and risks of depression, anxiety or post-traumatic stress disorder (PTSD), both for patients and their caregivers. We investigated correlations between outcomes and population characteristics. Results Of 50 ICU-survivors, seven died later and five were not contactable. Among 38 living patients, 33 participated (87%, 31 with their caregiver) with 2.7 years of median follow-up. Physical and mental SF-36 component scores were 42 (inter-quartile range, IQR:22) and 52 (IQR:18.5), respectively. The worst domains of the SF-36 were physical-role limitations (25, IQR:100) and general-health perception (56, IQR:42.5). Psychological tests highlighted high risk of depression (39-42%, patients; 39-52%, caregivers), anxiety (42%, patients; 39%, caregivers), and PTSD (47%, patients; 61%, caregivers). Patient depression or anxiety scores were correlated to age and to the outcome reported by caregivers. Conclusions At almost three-year follow-up, ARDS survivors treated with VV-ECMO showed reduced health-related quality-of-life and high risk of psychological impairment, in particular PTSD. Caregivers of this population were at high psychological risk as well.

10.23736/s0375-9393.19.13095-7https://pubmed.ncbi.nlm.nih.gov/31064171